Amgen Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Amgen (AMGN) PT Lowered to $182 at RBC Capital
October 31, 2018 7:00 AM EDTRBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $182.00 (from $193.00) while maintaining a Sector Perform rating.
... MoreAmgen (AMGN) Tops Q3 EPS by 24c, FY Guidance Tops Views
October 30, 2018 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q3 EPS of $3.69, $0.24 better than the analyst estimate of $3.45. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.77 billion.
GUIDANCE:
Amgen sees FY2018 EPS of $14.00-$14.25, versus the consensus of $14.02. Amgen sees... More



